Literature DB >> 11151463

Fetal heart rate monitoring: interpretation and collaborative management.

M Fox1, S Kilpatrick, T King, J T Parer.   

Abstract

Effective intrapartum fetal heart rate (FHR) monitoring requires ongoing collaboration among health care providers. Nurses, midwives, and physicians must have a shared understanding of 1) how FHR tracings are interpreted, 2) which FHR patterns are associated with actual or impending fetal acidemia, 3) when and within what time frame the physician or the midwife should be notified of variant FHR patterns, 4) how quickly physicians and midwives should respond when notified of variant patterns, and 5) the indications for and optimal timing of interventions such as operative delivery. This article reviews the literature on FHR monitoring and includes a discussion of the advantages and limitations of different monitoring modalities. An overview of those FHR patterns are associated with presumed fetal acidemia is presented, as well as sample multidisciplinary FHR monitoring guidelines and an exercise in intrapartum FHR pattern evaluation that can be used to initiate development of local FHR monitoring patterns.

Entities:  

Mesh:

Year:  2000        PMID: 11151463     DOI: 10.1016/s1526-9523(00)00069-6

Source DB:  PubMed          Journal:  J Midwifery Womens Health        ISSN: 1526-9523            Impact factor:   2.388


  3 in total

1.  The human factor: the critical importance of effective teamwork and communication in providing safe care.

Authors:  M Leonard; S Graham; D Bonacum
Journal:  Qual Saf Health Care       Date:  2004-10

2.  Severe asphyxia due to delivery-related malpractice in Sweden 1990-2005.

Authors:  S Berglund; C Grunewald; H Pettersson; S Cnattingius
Journal:  BJOG       Date:  2008-02       Impact factor: 6.531

3.  Altered autonomic control of heart rate variability in the chronically hypoxic fetus.

Authors:  C J Shaw; B J Allison; N Itani; K J Botting; Y Niu; C C Lees; D A Giussani
Journal:  J Physiol       Date:  2018-04-29       Impact factor: 5.182

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.